An Open Label Extension of a Study Comparing Topiramate and Amitriptyline in Migraine Prevention.
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the long-term safety and effectiveness of topiramate
for the prevention of migraine headaches in adults. Topiramate has been approved to prevent
migraine headaches in adults.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.